Robbins Sports Surfaces Becomes Primary Provider of NBA Game Courts

Robbins Sports Surfaces, the world's leading manufacturer of high-performance hardwood basketball courts, has become the primary manufacturer supplier of game courts for the NBA. With a rapidly expanding footprint throughout the league, Robbins now provides the main competition courts for the majority of NBA teams, reflecting the company's reputation for unmatched performance, precision engineering and […]

Clifton Mining Company (OTCBB: CFTN) (Clifton) – “Distribution and Production Update”

Notice of December 2025 Distribution – American Silver, LLC declared a $0.12 per member share distribution, which totaled $220,810 distributed to the Company, its largest single shareholder owing just over 20 percent (20%). For more information about the American Silver, LLC companies and products, please see the following websites: https://silverbiotics.com/, www.ablmedical.com, and https://ablmfg.com/. Production Update-

Transat A.T. Inc. Reports Results for the Fourth Quarter of Fiscal 2025

All-time record Adjusted EBITDA for fiscal 2025 Fiscal year highlights: — Revenues of $3,398.5 million, up 3.5% from $3,283.8 million for fiscal 2024 — Adjusted EBITDA1 of $271.0 million, compared to $203.2 million last year — Net income of $241.9 million ($6.06 per share), compared to a net loss of $114.0 million ($2.94 per share)

Aya Gold & Silver Files Preliminary Economic Assessment Technical Report for Boumadine Project

(TSX:AYA),(OTC US:AYASF),(Other OTC:AYASF), MONTREAL, Dec. 18, 2025 (GLOBE NEWSWIRE) — Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) is pleased to announce that it has filed a technical report presenting the Preliminary Economic Assessment (“PEA”) for the Boumadine Polymetallic Project (the “Project” or “Boumadine”), located in the Kingdom of Morocco,

Mutuum Finance (MUTM) Strengthens Security Framework with CertiK Review and Active Halborn Audit

DUBAI, United Arab Emirates, Dec. 18, 2025 (GLOBE NEWSWIRE) — Mutuum Finance (MUTM), a new crypto project in the decentralized finance sector, has reported progress on multiple fronts as it prepares for its next development milestones. The project recently confirmed the completion of a CertiK Token Scan review and an ongoing independent audit conducted by

Hydreight Exceeds 1.3 Million Product Orders Placed, Surpassing 2025 Operational Targets

(TSX-V:NURS),(Boerse Frankfurt – Freiverkehr:SO6),(OTC US:HYDTF),(Other OTC:HYDTF),(Boerse Frankfurt – Freiverkehr:SO6.F),(CNSX:VST.CN),(PinkSheets:VSQTF),(Boerse Frankfurt – Freiverkehr:6F6.F),(Boerse Frankfurt – Freiverkehr:6F6), VANCOUVER, British Columbia, Dec. 18, 2025 (GLOBE NEWSWIRE) — Hydreight Technologies Inc. (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6) (“Hydreight” or the “Company“), a leading provider of compliant digital health infrastructure and on-demand healthcare services across the United States, is pleased

Anfield Energy Announces Agreement to Acquire BRS Engineering, Bolstering In-House Technical Expertise for Uranium and Vanadium Projects

(TSX-V:AEC),(OTC US:ANLDF),(Other OTC:ANLDF),(Boerse Frankfurt – Freiverkehr:0AD),(NASDAQ:AEC),(Boerse Frankfurt – Freiverkehr:0ADN), VANCOUVER, British Columbia, Dec. 18, 2025 (GLOBE NEWSWIRE) — Anfield Energy Inc. (TSX.V: AEC; NASDAQ: AEC; FRANKFURT: 0AD) (“Anfield” or the “Company”) is pleased to announce that it has signed a definitive stock purchase agreement with Douglas L. Beahm, P.E., P.G., the Chief Operating Officer of

Sagimet Biosciences Announces Positive Results from the Phase 1 PK Clinical Trial of Denifanstat and Resmetirom Combination

(NasdaqGM:SGMT), The combination of denifanstat and resmetirom was generally well-tolerated Pharmacokinetic (PK) results support further development of the combination A Phase 2 trial of a denifanstat/resmetirom combination in F4 MASH patients is planned to initiate in 2H 2026 SAN MATEO, Calif., Dec. 18, 2025 (GLOBE NEWSWIRE) — Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical

Talisker Provides Update on Staff Reduction at Bralorne due to Atmospheric River Event in Southern British Columbia

(TSX:TSK),(OTC US:TSKFF),(Other OTC:TSKFF),(TSX:TSK-WT), TORONTO, Dec. 18, 2025 (GLOBE NEWSWIRE) — Talisker Resources Ltd. (“Talisker” or the “Company“) (TSX: TSK, OTCQX: TSKFF) announces that further to the Company's news release of December 17, 2025, the Company has successfully reduced staffing levels at the Bralorne Mine in accordance with its Emergency Response Plan in response to restricted

Avadel Pharmaceuticals Announces Completion of Enrollment in Phase 3 REVITALYZ(TM) Trial in Idiopathic Hypersomnia

(NasdaqGM:AVDL), – Data expected in Q2 2026 – DUBLIN, Dec. 18, 2025 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced the completion of patient enrollment in REVITALYZ, a Phase 3 trial evaluating LUMRYZTM (sodium oxybate) extended-release oral suspension as a potential treatment for idiopathic

Scroll to Top